(trans,trans)-4-Bromo-4'-ethyl-1,1'-bi(cyclohexane) CAS 389088-34-0
| CAS No. | 389088-34-0 |
| Molecular Formula | C14H25Br |
| Molecular Weight | 273.25 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
CATO supplies (trans,trans)-4-Bromo-4'-ethyl-1,1'-bi(cyclohexane) (CAS 389088-34-0), a certified reference material (molecular formula C14H25Br, MW 273.25 g/mol) for analytical method development and quality control.
(trans,trans)-4-Bromo-4'-ethyl-1,1'-bi(cyclohexane) (C14H25Br) contains bromine substitution. Halogen substitution raises its density and boiling point, its high carbon-to-hydrogen ratio confers good lipid solubility; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C14H25Br |
| Molecular Weight | 273.25 g/mol |
| Purity | 97%+ |
| Storage | Store at room temperature, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate |
| Stability | Stable under recommended storage conditions |
| Degree of Unsaturation (DBE) | 2.0 |
| CAS Registry Year (est.) | 2025 |
| Halogen Content | Br-containing |
Recommended Standards
- (S)-3-(Trifluoromethyl)-7,7a,8,9,10,11-hexahydro-6H-pyrazino[1,2-d]pyrido[3,2-b][1,4]oxazepine (CAS 2817668-75-8)
- 1-(3-(Trifluoromethyl)phenyl)piperidine-4-carboxylic acid (CAS 847407-02-7)
- (R)-3-(Trifluoromethyl)-7,7a,8,9,10,11-hexahydro-6H-pyrazino[1,2-d]pyrido[3,2-b][1,4]oxazepine (CAS 2830559-80-1)
- 1-(4-Trifluoromethylphenyl)piperidine-4-carboxylic acid (CAS 607354-69-8)
- N-(Piperidin-4-ylmethyl)pyrimidin-2-amine hydrochloride (CAS 1185314-62-8)
- 4-(Adamantan-1-yl)aniline (CAS 1459-48-9)
- N,N'-Bis(2,4-difluorophenyl)urea (CAS 1581-06-2)
- 3,5-Difluoro-4-(1-pyrrolidinylcarbonyl)phenylboronic acid (CAS 1264616-16-1)
- 1-((4-(4-Fluorophenyl)-6-methoxy-2H-chromen-3-yl)methyl)pyrrolidine (CAS 1370544-73-2)
- 3-Iodo-2-methyl-6-nitro-2H-indazole (CAS 2007921-28-8)
- 1-(3,4-Dichlorophenyl)ethanol (CAS 1475-11-2)
- (2-(4-Iodo-1h-pyrazol-1-yl)pyridin-3-yl)methanamine (CAS 1341185-75-8)
- 4-[2-(2-Chloro-4-fluorophenoxy)ethyl]piperidinehydrochloride (CAS 1220036-86-1)
- [5-31]-Semaglutide (CAS CATO-C4X-2226263)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com